Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer

American Journal of Surgery

Volumn 197, Issue 4, 2009, Pages 544-549

  Crozier, Joseph E M ^a   Leitch, E Fiona ^a   McKee, Ruth F ^a   Anderson, John H ^a   Horgan, Paul G ^a   McMillan, Donald C ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Albumin; C reactive protein; Colon cancer; Emergency presentation; Survival

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; EMERGENCY CARE; FEMALE; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; HYPOALBUMINEMIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; C-REACTIVE PROTEIN; COLECTOMY; COLONIC NEOPLASMS; EMERGENCIES; FEMALE; HUMANS; HYPOALBUMINEMIA; MALE; MIDDLE AGED; SERUM ALBUMIN; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 62649149414     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.12.052     Document Type: Article

References (30)

1. Cancerstats. www.cancerresearchuk.org 2004. Accessed August 2007
2. Phillips R.K.S., Hittinger R., Fry J.S., et al. Malignant large bowel obstruction. Br J Surg 72 (1985) 296-302
3. Scott N.A., Jeacock J., and Kingston R.D. Risk factors in patients presenting as an emergency with colorectal cancer. Br J Surg 82 (1995) 321-323
4. McArdle C.S., and Hole D.J. Emergency presentation of colorectal cancer is associated with poor 5-year survival. Br J Surg 91 (2004) 605-609
5. McArdle C.S., McMillan D.C., and Hole D.J. The impact of blood loss, obstruction and perforation on overall and cancer specific survival in patients undergoing curative resection for colon cancer. Br J Surg 93 (2006) 483-488
6. Heys S.D., Walker L.G., Deehan D.J., et al. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43 (1988) 163-168
7. Nielsen H.J., Christensen I.J., Sorensen S., et al. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 7 (2000) 617-623
8. McMillan D.C., Canna K., and McArdle C.S. A systemic inflammatory response predicts survival following curative resection for colorectal cancer. Br J Surg 90 (2003) 215-219
9. McMillan D.C., Crozier J.E.M., Canna K., et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing potentially curative resection for colorectal cancer. Int J Colorectal Dis 22 (2007) 881-886
10. Leitch E.F., Chakrabarti M., Crozier J.E.M., et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 97 (2007) 1266-1270
11. Carstairs V., and Morris R. Deprivation and Health in Scotland (1991), University Press, Aberdeen, Scotland
12. Hole D.J., and McArdle C.S. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg 89 (2002) 586-590
13. American Joint Committee on Cancer. Colon and rectum. In: Greene F.L., Page D.L., and Fleming I.D. (Eds). AJCC Cancer Staging Manual. Ed 6 (2002), Springer, New York, NY 113-124
14. Forrest L.M., McMillan D.C., McArdle C.S., et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small cell lung cancer. Br J Cancer 89 (2003) 1028-1030
15. Gibbs J., Cull W., Henderson W., et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134 (1999) 36-42
16. Franch-Arcas G. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr 20 (2001) 265-269
17. Heys S.D., Walker L.G., Deehan D.J., et al. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43 (1998) 163-168
18. Longo W.E., Virgo K.S., Johnson F.E., et al. Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program. Ann Surg 228 (1998) 64-70
19. Longo W.E., Virgo K.S., Johnson F.E., et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 43 (2000) 83-91
20. McMillan D.C., Watson W.S., O'Gorman P., et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39 (2001) 210-213
21. McMillan D.C., Elahi M.M., Sattar N., et al. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41 (2001) 64-69
22. Crumley A.B., McMillan D.C., McKernan M., et al. Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94 (2006) 637-641
23. Glen P., Jamieson N.B., McMillan D.C., et al. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6 (2006) 450-453
24. Preston T., Slater C., McMillan D.C., et al. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 128 (1998) 1355-1360
25. McMillan D.C., Scott H.R., Watson W.S., et al. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31 (1998) 101-105
26. Vermeire S., Van Assche G., and Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 580-586
27. Nozoe T., Matsumata T., and Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23 (2000) 263-266
28. Canna K., McArdle P.A., McMillan D.C., et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92 (2005) 651-654
29. Du Clos T.W., and Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res 30 (2004) 261-277
30. Ytting H., Christensen I.J., Basse L., et al. Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol 144 (2006) 239-246